Background: Chronic obstructive pulmonary disease (COPD) is a non-specific inflammation, which involves the airways, lung parenchyma and pulmonary vessels. The inflammation causes the activation of inflammatory cells and the release of various inflammatory mediators such as interleukin-8 (IL-8), IL-6 and tumor necoris factor alpha (TNF-a). The purpose of the present study was to measure serum IL-6, C-reactive protein (CRP) (as a positive phase reactant) and albumin level (as a negative phase reactant) in COPD patients (only due to cigarette smoking not bio-mass), non COPD smokers and healthy subjects using enzyme-linked immunosorbent assay (ELISA); we compared the differences in inflammatory factors among groups. Materials and Methods: A total of 180 males were enrolled in this study and divided into three equal groups. The first group was 60 smokers who had COPD. The second group included 60 smokers without COPD and the third group consisted of people who were not smokers and did not have COPD; 5 mL of venous blood was taken from all participants and it was collected in a test tube containing anticoagulant and then centrifuged at 3000 rpm for 10 minutes. Serum was separated and used to measure the amount of IL-6, CRP and albumin. Spirometry was performed according to the criteria set by the American Thoracic Society. Results: The mean serum level of IL-6 was 83.2±7.5 pg/mL in group I, 54.9±24.3 pg/mL in group II and 46.9±10.4 pg/mL in group III. There was a significant difference among the three groups (P<0.001). The mean serum level of CRP was 28.9±14.9 mg/dL in the first group, 19.9±8.5 mg/dL in the second group and 4.2±2.3 mg/dL in the third group (P=0.02). But by controlling the confounding effects of age, this difference was not significant (P=0.49). The mean serum level of albumin was I 4.1±0.57 mg/dL in group I, 4.3±0.56 mg/dL in group II and 4.1±0.53 mg/dL in group III. There was no significant difference among the three groups in this regard (P=0.099).There was a significant inverse relationship between serum levels of IL-6 and FEV 1 (r=-0.341, P<0.001). Moreover, there was a significant inverse relationship between serum levels of IL-6 and FEV1/FVC (r=-0.309, P<0.001). Serum albumin level was not different among various stages. Level of CRP and IL6 increased as the stage of COPD got worse in smokers. Conclusion: Our study showed that serum level of IL-6 predicts development of COPD in smokers with a high sensitivity among all inflammatory factors namely CRP, IL-6, and albumin.
INTRODUCTION
Chronic obstructive pulmonary disease is the most prevalent cause of morbidity and mortality due to lung diseases in both developing and developed countries (1) .
The global initiative for lung disease (GOLD) has estimated that this disease is probably going to be the third
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Emami Ardestani M, et al. 135 Tanaffos 2015; 14 (2) : [134] [135] [136] [137] [138] [139] [140] cause of death worldwide by the year 2020 (2) . The cause of death in COPD is not only respiratory failure, but also cardiovascular complications, lung cancer or other causes which often remain unrecognized (3) . Risk factors of COPD include: 1) Cigarette smoking, 2) Occupational exposures (dust and fumes, coal mining, gold mining, cotton textile dust) and 3) α1 antitrypsin deficiency etc. Cigarette smoking is a major risk factor for mortality from chronic bronchitis and emphysema. Chronic exposure to cigarette smoke may lead to inflammatory cell recruitment within the terminal air spaces of the lung (4).
Chronic obstructive pulmonary disease is a nonspecific inflammation, which occurs in the airways, lung parenchyma and pulmonary vessels. The process leading to COPD development is heterogeneous (5) . Several Many recent studies indicated that CRP levels are related to important clinical outcomes, including exercise tolerance, health status and COPD exacerbation (7, (8) (9) (10) (11) (12) . Serum proteins are affected by inflammation. Albumin is a negative acute phase reactant and albumin levels decrease during the acute phase response due to increase in catabolism of albumin (13) .
The purpose of this study was to investigate the plasma level of IL-6 as a main inflammatory factor, CRP as a positive acute phase reactant and albumin as a negative phase reactant in smoker COPD patients and compare it with smoker non-COPD individuals and healthy controls.
MATERIALS AND METHODS

Study Design
This was a comparative-descriptive study that was done from 2013 to 2014 at Al-Zahra Hospital in Isfahan, Iran. The institutional review board approved the study.
The COPD patients were selected among male patients referred to the Pulmonary Clinic of Al-Zahra Hospital in Isfahan. Participants were divided into three groups. The first group was 60 smokers who had stable COPD. This group had a history of chronic cough, sputum, persistent dyspnea and cigarette smoking (no inhalation of bio-mass). 
Statistical analysis
The quantitative data among three groups were analyzed by one-way ANOVA. To assess the relationship between laboratory findings associated with inflammation (IL6) and spirometric parameters, we used the Pearson's correlation, ANCOVA and regression analysis. A value of P< 0.05 was taken to indicate statistical significance. All data were reported as mean ± standard deviation (SD).
Analysis was done using SPSS software version 22.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
The 180 male candidates enrolled in this study were divided into three equal groups. The first group was a number of smokers with COPD, the second group included a number of smokers without COPD and the third group consisted of people who were not smokers, and did not have COPD. The mean age of the participants was 59.1±13.6 years in the first group, 48.2±12.3 years in group II, and 39.9 ± 11.8 years in the third group. The mean serum level of IL-6 was 83.2±7.5 pg/mL in group I, 54.9±24.3 pg/mL in group II and 46.9 ± 10.4 pg/mL in the third group. There was a significant difference among the three groups in this regard (P<0.001). The mean serum CRP level was 28.9 ± 14.9 mg/dL in the first group, and by controlling the confounding effect of age this result did not change (P=0.099, Table 1 ). (19, 20) . Cigarette smoking is a major risk factor for mortality from chronic bronchitis and emphysema. Chronic exposure to cigarette smoke may lead to inflammatory cell recruitment within the terminal air spaces of the lung (4).
The level of IL-6 in plasma is known as a powerful cause of CRP production in the liver (21), and is associated with CRP levels in COPD patients (10, 22, 23) . In this study, the CRP mean values were significantly different among the three groups but by controlling for the confounding effect of age this difference disappeared (P=0.49).
Therefore, the effect of age is a main cause for different CRP mean values in the groups. The mean serum level of IL6 was significanltly different among the groups as well.
Thus, we can conclude that the mean serum level of IL6 is a more sensitive biomarker to predict inflammation. The plasma level of IL-6 also has shown a relation to malnutrition pathophysiology since it increases in lowweight COPD patients (13). As we know, malnutrition has a corelation to decreased levels of serum albumin. In our study, the mean level of serum albumin did not have significant differences among groups and was in the normal range; thus, the participants did not have malnutrition. We conclude that increase in level of IL6 did not correlate with malnutrition. Pinto-Plata et al.
demonstrated that the mean value of CRP remained stable over a 17-month period. Pinto-Plata et al, in another cohort study indicated that the highest level of inflammatory markers was related to the degree of airflow obstruction, functional capacity and health status (25, 26) . In this study, the mean CRP mean values and level of IL6 increased proportionally with severity of COPD (Gold criteria).
Kolsum et al. has shown that IL-6 did not change over oneyear (23) . One study showed that chronic systemic inflammation, especially when lasting for at least one year, was associated with a higher incidence of exacerbations and short survival (27) . Furthermore, many additional studies showed that the rise in white blood cell counts and plasma level of IL-6, fibrinogen, CRP, chemokine ligand 18, IL-8, and surfactant protein D can predict mortality and morbidity in COPD patients (18, 28, 29) .
As a matter of fact, IL-6 regulates many pathways that could contribute to its effect on inflammatory disease Fibrinogen is another inflammatory factor, which can be used in COPD diagnosis and exacerbation. Also, fibrinogen, an acute phase protein, increases during airway colonization and other comorbidities such as heart failure, diabetes mellitus, and lung cancer (18, 29 (12, 36) . In this study, we demonstrated that the CRP mean values did not change significantly in the groups upon controlling the confounding effect of age (P>0.05).
We found that between the three groups of participants only serum levels of IL-6 predicted the development of COPD in smokers with a high sensitivity. It seems that a serum level of IL-6 in addition to cigarette smoking is associated with age which should be considered in future studies. Furthermore, the smokers without COPD had increased serum levels of IL-6. This can predict the probability of COPD development in smokers with high serum IL-6 levels which confirms this hypothesis but requires further study.
We demonstrated that an increased serum level of IL-6
was associated with a decrease in FEV1 and FEV1/FVC.
We can estimate FEV1, FEV1/FVC from the amount of serum IL-6. Thus, we propose the below mathematical formula for this:
[FEV1=0.777 -(0.001 IL-6), FEV1/FVC=0.793 -(0.001 IL-6)]
In conclusion, our study showed that the serum level of IL-6 predicts the development of COPD in smokers with a high sensitivity among all these inflammatory factors such as CRP, IL-6, and serum albumin.
